Left Atrial Appendage Closure

Mechanical Approaches to Stroke Prevention in Atrial Fibrillation

Inbunden, Engelska, 2015

AvJacqueline Saw,Saibal Kar,Matthew J. Price,M.D. Price, Matthew J.

1 949 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Percutaneous left atrial appendage (LAA) closure is an emerging technology for thromboembolic prevention in patients with atrial fibrillation (AF). The first human implantation of an LAA device occurred in 2001, and since then four devices have received CE mark approval.

Produktinformation

Utgivningsdatum2015-11-18
Mått155 x 235 x 22 mm
Vikt692 g
FormatInbunden
SpråkEngelska
SerieContemporary Cardiology
Antal sidor300
Upplaga15001
FörlagSpringer International Publishing AG
ISBN9783319162799

Tillhör följande kategorier

Thoraxkirurgi och hjärtkirurgi inom Medicin
Hjärt- och kärlsjukdomar inom Medicin
Medicinsk bildbehandling inom Medicin

Jacqueline Saw, MD, FRCPC, FACC, FSCAI Clinical Associate Professor University of British Columbia Head, VGH Cardiology Clinical Trials Research Program Director, VGH Interventional Cardiology Fellowship Vancouver General Hospital 2775 Laurel Street, Level 9 Vancouver, V5Z1M9, British Columbia Canada Saibal Kar, MD, FACC Director, Interventional Cardiology Research Cedars-Sinai Medical Center 8631 W. 3rd Street, #415E Los Angeles, CA 90048 Matthew J. Price, MD, FACC, FSCAI Director, Cardiac Catheterization Laboratory Division of Cardiovascular Diseases Scripps Clinic Assistant Professor Scripps Translational Science Institute 10666 North Torrey Pines Road, Maildrop S1056 La Jolla, CA 92037 Jacqueline Saw is the editor of Carotid Artery Stenting: The Basics (978-1-60327-313-8, 2009) and Handbook of Complex Percutaneous Carotid Intervention (978-1-58829-605-4, 2007), both of which are volumes in the Contemporary Cardiology series.

Atrial fibrillation and stroke epidemiology.- Efficacy and limitations of warfarin, and novel oral anticoagulants with AF.- Mechanistic rationale for LAA closure with AF and stroke prevention.- LAA anatomy.- Conventional surgery for LAA closure.- The use of transesophageal echocardiography to guide percutaneous LAA closure.- The use of intracardiac echocardiography to guide procedural LAA closure.- The use of cardiac CTA to guide percutaneous LAA closure.- PLAATO device.- WATCHMAN device.- WATCHMAN: Trials and registries results.- Amplatzer Cardiac Plug (ACP) and Amulet.- ACP and Amulet: Trials and registries results.- LARIAT.- LARIAT: Trials and registries results.- Novel percutaneous LAA closure devices in clinical or pre-clinical trials.- Concomitant AF ablation and LAA closure.- Procedural complications and management.- Antiplatelet and anticoagulant strategies after LAA closure.- Device-related thrombi, residual leaks and consequences.